An Efficacy and Safety Study of Mitiperstat (AZD4831) (MPO Inhibitor) vs Placebo in the Treatment of Moderate to Severe COPD.

PHASE2CompletedINTERVENTIONAL
Enrollment

381

Participants

Timeline

Start Date

November 14, 2022

Primary Completion Date

August 12, 2024

Study Completion Date

August 12, 2024

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Mitiperstat (AZD4831)

Oral dosage, once daily.

OTHER

Placebo

Oral dosage, once daily.

Trial Locations (101)

1756

Research Site, Sofia

1886

Research Site, Ranelagh

1935

Research Site, Vereeniging

2300

Research Site, Pernik

2400

Research Site, København NV

2602

Research Site, Dupnitsa

2650

Research Site, Hvidovre

3000

Research Site, Vratsa

4001

Research Site, Durban

4093

Research Site, Durban

4700

Research Site, Næstved

5000

Research Site, Odense C

6000

Research Site, Stara Zagora

6003

Research Site, Stara Zagora

6305

Research Site, Haskovo

7000

Research Site, Rousse

7100

Research Site, Vejle

7530

Research Site, Tygervalley

7700

Research Site, Cape Town

9000

Research Site, Aalborg

10119

Research Site, Berlin

12553

Research Site, New Windsor

18014

Research Site, Granada

27284

Research Site, Kernersville

28007

Research Site, Madrid

28054

Research Site, Gastonia

28562

Research Site, New Bern

29010

Research Site, Málaga

29707

Research Site, Fort Mill

32720

Research Site, DeLand

32789

Research Site, Winter Park

32825

Research Site, Orlando

33186

Research Site, Miami

33343

Research Site, Mersin

33606

Research Site, Tampa

33765

Research Site, Clearwater

34376

Research Site, Immenhausen

34854

Research Site, Istanbul

34890

Research Site, Istanbul

35037

Research Site, Marburg

35360

Research Site, Izmir

37134

Research Site, Verona

39008

Research Site, Santander

43215

Research Site, Columbus

44670

Research Site, Guadalajara

45138

Research Site, Zapopan

48109

Research Site, Ann Arbor

53100

Research Site, Siena

56068

Research Site, Koblenz

58452

Research Site, Witten

60415

Research Site, Chicago Ridge

60596

Research Site, Frankfurt

63017

Research Site, Chesterfield

63301

Research Site, Saint Charles

64310

Research Site, Monterrey

64465

Research Site, Monterrey

71100

Research Site, Foggia

73020

Research Site, Choctaw

79106

Research Site, Amarillo

80200

Research Site, Culiacán

86899

Research Site, Landsberg

91910

Research Site, Veracruz

92663

Research Site, Newport Beach

C1121ABE

Research Site, Buenos Aires

C1414AIF

Research Site, Buenos Aires

C1425BEN

Research Site, Buenos Aires

X5003DCE

Research Site, Córdoba

B1646EBJ

Research Site, San Fernando

T3B 0M3

Research Site, Calgary

G1V 4G5

Research Site, Québec

G3K 2P8

Research Site, Québec

J6E 2B4

Research Site, Saint-Charles-Borromée

G8T 7A1

Research Site, Trois-Rivières

04299

Research Site, Leipzig

00168

Research Site, Roma

07100

Research Site, Sassari

9713 GH

Research Site, Groningen

5504 DB

Research Site, Veldhoven

43-300

Research Site, Bielsko-Biala

26-060

Research Site, Chęciny

05-480

Research Site, Karczew

31-011

Research Site, Krakow

95-054

Research Site, Ksawerów

28-200

Research Site, Staszów

70-111

Research Site, Szczecin

01-456

Research Site, Warsaw

06800

Research Site, Mérida

01330

Research Site, Adana

06620

Research Site, Ankara

BD9 6RJ

Research Site, Bradford

CB2 0QQ

Research Site, Cambridge

HU16 5JQ

Research Site, Cottingham

DD1 9SY

Research Site, Dundee

G12 0YN

Research Site, Glasgow

EC1M 6BQ

Research Site, London

NW3 2QG

Research Site, London

M8 5RB

Research Site, Manchester

NG5 1PB

Research Site, Nottingham

S65 2QL

Research Site, Rotherham

WF1 4DG

Research Site, Wakefield

YO24 3WX

Research Site, York

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY